Search research articles
Contact Us
Filters
Showing results (101-110 of 218) with videos related to
Page
of 22
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 22, 2021
Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion method
U Mrowietz, R B Warren, C L Leonardi, et al.
Genes and Immunity
|
May 16, 2008
Association analysis of IL20RA and IL20RB genes in psoriasis
K Kingo, R Mössner, R Rätsep, et al.
Dermatology (Basel, Switzerland)
|
March 10, 2009
Health services research in psoriasis--the German approach
M Augustin, K Reich, M Reusch, et al.
The Journal of Experimental Medicine
|
January 1, 1992
Oligoclonality of human intestinal intraepithelial T cells
C Van Kerckhove, G J Russell, K Deusch, et al.
Archives of Oral Biology
|
June 30, 2009
Periodontal histomorphometry and status of aged sheep subjected to ovariectomy, malnutrition and glucocorticoid application
G Dvorak, K Reich, S Tangl, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 26, 2020
Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post hoc analysis through 64 weeks from reSURFACE 1 trial
R B Warren, J M Carrascosa, E Fumero, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 23, 2018
Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trials
A Blauvelt, K Reich, M Lebwohl, et al.
Clinical and Experimental Dermatology
|
January 4, 2017
Psoriasis and metabolic syndrome in children: current data
A Pietrzak, E Grywalska, M Walankiewicz, et al.
The British Journal of Dermatology
|
September 6, 2019
Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studies
A B Kimball, K A Papp, K Reich, et al.
The British Journal of Dermatology
|
June 28, 2003
Cytokine gene polymorphisms in atopic dermatitis
K Reich, G Westphal, I R König, et al.
Page
of 22
Search research articles
Search
Showing results (101-110 of 218) with videos related to
Sort By:
Page
of 22
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 22, 2021
Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion method
U Mrowietz, R B Warren, C L Leonardi, et al.
Genes and Immunity
|
May 16, 2008
Association analysis of IL20RA and IL20RB genes in psoriasis
K Kingo, R Mössner, R Rätsep, et al.
Dermatology (Basel, Switzerland)
|
March 10, 2009
Health services research in psoriasis--the German approach
M Augustin, K Reich, M Reusch, et al.
The Journal of Experimental Medicine
|
January 1, 1992
Oligoclonality of human intestinal intraepithelial T cells
C Van Kerckhove, G J Russell, K Deusch, et al.
Archives of Oral Biology
|
June 30, 2009
Periodontal histomorphometry and status of aged sheep subjected to ovariectomy, malnutrition and glucocorticoid application
G Dvorak, K Reich, S Tangl, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 26, 2020
Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post hoc analysis through 64 weeks from reSURFACE 1 trial
R B Warren, J M Carrascosa, E Fumero, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 23, 2018
Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trials
A Blauvelt, K Reich, M Lebwohl, et al.
Clinical and Experimental Dermatology
|
January 4, 2017
Psoriasis and metabolic syndrome in children: current data
A Pietrzak, E Grywalska, M Walankiewicz, et al.
The British Journal of Dermatology
|
September 6, 2019
Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studies
A B Kimball, K A Papp, K Reich, et al.
The British Journal of Dermatology
|
June 28, 2003
Cytokine gene polymorphisms in atopic dermatitis
K Reich, G Westphal, I R König, et al.
Page
of 22